Location: United States.
A specific layoff date has not been disclosed.
Based on news reporting.
Novo Nordisk has announced plans to cut approximately 300 jobs in the United States as part of a strategic move to adapt to the competitive landscape of weight-loss drugs. This decision comes amid increasing pressure from rivals in the pharmaceutical industry. The layoffs are part of a broader restructuring effort aimed at maintaining the company's market position. Specific details regarding the timeline for these job cuts have not been disclosed, but the company is actively working to implement these changes. The layoffs reflect the challenges faced by Novo Nordisk in a rapidly evolving market.
Novo Nordisk cut 300 jobs.
That is roughly 0.7% of the 45,000 people Novo Nordisk employs.
LayoffTalk has tracked 37 layoff events at Novo Nordisk since October 2023, affecting a combined 43,047 employees.
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Estimated figure based on news reporting. Not yet confirmed by Novo Nordisk.
Share your story anonymously — it helps others reading this feel less alone.
Share your story →Recent tracked events at this company.